Search research articles
Contact Us
Filters
Showing results (1-10 of 91) with videos related to
Page
of 10
Sort By:
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
October 12, 1999
Functions of the retinoblastoma protein
W G Kaelin
Science (New York, N.Y.)
|
July 25, 1998
Another p53 Doppelgänger?
W G Kaelin
Cold Spring Harbor Symposia on Quantitative Biology
|
July 28, 2006
The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing
W G Kaelin
Annals of the New York Academy of Sciences
|
June 9, 1998
Alterations in G1/S cell-cycle control contributing to carcinogenesis
W G Kaelin
Nature
|
June 3, 1999
Cancer. Many vessels, faulty gene
W G Kaelin
The Journal of Clinical Investigation
|
December 10, 1999
Taking aim at novel molecular targets in cancer therapy
W G Kaelin
The Journal of Clinical Investigation
|
December 10, 1999
Choosing anticancer drug targets in the postgenomic era
W G Kaelin
Journal of the National Cancer Institute
|
April 15, 1999
The emerging p53 gene family
W G Kaelin
Oncogene
|
January 5, 2000
The p53 gene family
W G Kaelin
Cold Spring Harbor Symposia on Quantitative Biology
|
November 18, 2011
Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases
W G Kaelin
Page
of 10
Search research articles
Search
Showing results (1-10 of 91) with videos related to
Sort By:
Page
of 10
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
October 12, 1999
Functions of the retinoblastoma protein
W G Kaelin
Science (New York, N.Y.)
|
July 25, 1998
Another p53 Doppelgänger?
W G Kaelin
Cold Spring Harbor Symposia on Quantitative Biology
|
July 28, 2006
The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing
W G Kaelin
Annals of the New York Academy of Sciences
|
June 9, 1998
Alterations in G1/S cell-cycle control contributing to carcinogenesis
W G Kaelin
Nature
|
June 3, 1999
Cancer. Many vessels, faulty gene
W G Kaelin
The Journal of Clinical Investigation
|
December 10, 1999
Taking aim at novel molecular targets in cancer therapy
W G Kaelin
The Journal of Clinical Investigation
|
December 10, 1999
Choosing anticancer drug targets in the postgenomic era
W G Kaelin
Journal of the National Cancer Institute
|
April 15, 1999
The emerging p53 gene family
W G Kaelin
Oncogene
|
January 5, 2000
The p53 gene family
W G Kaelin
Cold Spring Harbor Symposia on Quantitative Biology
|
November 18, 2011
Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases
W G Kaelin
Page
of 10